Document Detail

Boceprevir and telaprevir for the treatment of chronic hepatitis C: safety management in clinical practice.
MedLine Citation:
PMID:  22212569     Owner:  NLM     Status:  In-Data-Review    
Effective management of adverse events (AEs) is important to prevent treatment discontinuation and optimize hepatitis C virus infection eradication rates. The addition of direct-acting antiviral agents, telaprevir (TVR) or boceprevir to pegylated interferon (PEG-IFN) and ribavirin (RBV) represents a new era of therapy associated with an improvement in treatment response rates and an impairment of the safety profile compared to PEG-IFN/RBV. An increase in the frequency and severity of anaemia was reported in clinical trials for both drugs, and skin disorders including rash and pruritus occurred more frequently with the TVR-based regimen. These AEs are generally manageable and do not lead to early discontinuation. The management of anaemia has not been clearly established, and the impact of RBV dose reductions and erythropoietin alpha use on treatment efficacy and safety must be clarified. The management of rashes, which were mild and moderate in more than 90% of the cases, is well planned, does not require TVR discontinuation and can be treated using emollients and topical corticosteroids. However, approximately 5% of rashes were severe, and a few cases were classified as severe cutaneous adverse reactions leading to treatment discontinuation.
Christophe Hézode
Related Documents :
21561049 - Doctors and padma awards.
24173429 - A strategy for trade monitoring and substitution of the organs of threatened animals.
23964849 - Odorant receptors of a primitive hymenopteran pest, the wheat stem sawfly.
25147999 - What i need to start my job: a wish list (positioning yourself for success in an academ...
25398959 - The national practice benchmark for oncology, 2014 report on 2013 data.
18468169 - Preparation and luminescent properties of yvo4:eu3+ nanofibers by electrospinning.
25225479 - Endocrinology and adolescence: congenital hypothyroidism a clinical update of long-term...
12400869 - Empirical and theoretical evidence for herd size as a risk factor for swine diseases.
23735479 - Hericium erinaceus: an edible mushroom with medicinal values.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Liver international : official journal of the International Association for the Study of the Liver     Volume:  32 Suppl 1     ISSN:  1478-3231     ISO Abbreviation:  Liver Int.     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-01-03     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101160857     Medline TA:  Liver Int     Country:  England    
Other Details:
Languages:  eng     Pagination:  32-8     Citation Subset:  IM    
Copyright Information:
© 2012 John Wiley & Sons A/S.
Department of Hepatology and Gastroenterology, Hôpital Henri Mondor, Université Paris-Est, Créteil, France; INSERM U955, Créteil, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Phase III results of Boceprevir in treatment naïve patients with chronic hepatitis C genotype 1.
Next Document:  Phase III results in Genotype 1 naïve patients: predictors of response with boceprevir and telaprev...